drugset / Trial / NCT00002200

A Study of 1592U89 in HIV-Infected Adults

NCT00002200

Completed Glaxo Wellcome
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give 1592U89 to HIV-positive adults. This study also examines the influence previous anti-HIV treatment has on the effectiveness of 1592U89.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified Oral